PubRank

G Noseda

Author PubWeight™ 32.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Short-term effects of atorvastatin on C-reactive protein. Eur Heart J 2002 2.15
2 Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res 2000 1.42
3 Metabolic properties of human IgA subclasses. Clin Exp Immunol 1973 1.26
4 Antibodies against lipoproteins in man. Occurrence and biological significance. Klin Wochenschr 1975 0.94
5 Hypocholesterolemia in idiopathie hirsutism. N Engl J Med 1973 0.90
6 Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency. Arterioscler Thromb Vasc Biol 1995 0.88
7 Hypo- -lipoproteinaemia associated with auto-antibodies against -lipoproteins. Eur J Clin Invest 1972 0.86
8 Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I. J Lipid Res 1998 0.85
9 Anti- -lipoprotein activity of human monoclonal immunoglobulins. Vox Sang 1972 0.84
10 [Causal relationship between the use of oral contraceptives and neurological complications? Presentation of a case of extensive cerebral vein thrombosis]. Munch Med Wochenschr 1967 0.84
11 Separation between HIV-positive women and their children: the French prospective study, 1986 through 1993. Am J Public Health 1996 0.82
12 Evaluation of Roentgen cinedensitometry for flow measurement in models and in the intact circulation. Circulation 1967 0.82
13 Approach to fluid dynamic problems in reconstructive vascular surgery. Surgery 1969 0.82
14 [Pericarditis and myocarditis in salmonellosis]. Schweiz Med Wochenschr 1980 0.81
15 [Rendu Osler disease revealed by ruptured cerebral arterial aneurysm in an infant]. Arch Fr Pediatr 1990 0.81
16 [Autoantibodies against lipoproteins and hypolipidemia in seronegative primary chronic polyarthritis]. Schweiz Med Wochenschr 1972 0.80
17 [Heavy chain disease. A case of IgG-heavy-chain-fragment and IgM-type K-paraproteinemia with plasma cell leukemia]. Schweiz Med Wochenschr 1970 0.79
18 Aortic and coronary atheromatosis in a woman with severe hypercholesterolaemia without LDL receptor alterations. Eur Heart J 1991 0.79
19 [Binding of beta-lipoprotein by an IgA paraprotein: an antigen-antibody reaction?]. Schweiz Med Wochenschr 1971 0.79
20 [Effect of heart rate increase on the dynamics of the left ventricle during electrical atrial stimulation and Isuprel infusion in humans]. Verh Dtsch Ges Inn Med 1968 0.79
21 Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study). Int J Clin Pharmacol Ther 1995 0.79
22 Fecal cholesterol excretion studies in type II hypercholesterolemic patients treated with the soybean protein diet. Atherosclerosis 1982 0.79
23 Hypercholesterolaemia treated by soybean protein diet. Arch Dis Child 1987 0.79
24 [Forearm blood flow and circulation times in heart failure]. Schweiz Med Wochenschr 1969 0.79
25 A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas. Arterioscler Thromb 1994 0.79
26 [Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study]. Schweiz Med Wochenschr 1993 0.78
27 Autoantibodies with antilipoprotein specificity and hypolipoproteinemia in patients with cancer. Cancer Res 1975 0.78
28 Acute bilateral striatal necrosis in an infant: CT and MRI. Neuroradiology 1994 0.78
29 [Hairy cell leukemia and myeloma]. Schweiz Med Wochenschr 1980 0.78
30 Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia. Atherosclerosis 1984 0.78
31 [Postopeative follow-up studies of mitral valve diseases by means of peripheral dye and apnea curves for up to 6 years after surgery]. Schweiz Med Wochenschr 1968 0.77
32 Pharmacokinetics of defibrotide in healthy volunteers. Haemostasis 1986 0.77
33 [Epidural hematoma in a child with hemophilia: diagnostic difficulties]. Arch Pediatr 2001 0.77
34 Blood flow measurement through single coronary arteries by roentgen densitometry. I. A comparison of flow measured by a radiologic technique applicable in the intact organism and by electromagnetic flowmeter. Am J Roentgenol Radium Ther Nucl Med 1970 0.76
35 [Anti-lipoprotein autoantibodies with hypolipidemia in infectious rheumatism]. Schweiz Med Wochenschr 1975 0.76
36 Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients. Atherosclerosis 1998 0.76
37 [Clinical trial of tibric acid, a new hypolipidemic agent]. Schweiz Med Wochenschr 1974 0.76
38 [Heart muscle and hypertonia]. Schweiz Med Wochenschr 1968 0.76
39 [Unusual autoimmune and neoplastic associated diseases in Sjogren's syndrome]. Schweiz Med Wochenschr 1979 0.75
40 [The behavior of serum lipids in paraproteinemias. Demonstration of paraprotein-lipoprotein complexes]. Schweiz Med Wochenschr 1971 0.75
41 [Beta blockaders and arrhythmias]. Schweiz Rundsch Med Prax 1973 0.75
42 [Fat embolism syndrome without fractures]. Schweiz Med Wochenschr 1978 0.75
43 [Analbuminemia]. Minerva Med 1972 0.75
44 [Clofibrate--helpful or harmful?]. Schweiz Med Wochenschr 1979 0.75
45 [Blood lipids in the Swiss population: MONICA study 1988-89]. Schweiz Med Wochenschr Suppl 1993 0.75
46 [Cholesterol embolism: a heavy price to pay after successful fibrinolysis]. Schweiz Med Wochenschr 1994 0.75
47 Mycoplasma pneumoniae postinfectious encephalomyelitis with bilateral striatal necrosis. Mov Disord 1996 0.75
48 [Contraindications in the surgical intervention in acquired heart failure]. Schweiz Med Wochenschr 1967 0.75
49 Blood flow measurement through single coronary arteries by roentgen densitometry. Right coronary artery flow in conscious man. Am J Roentgenol Radium Ther Nucl Med 1970 0.75
50 The soybean protein diet does not lower plasma cholesterol? Atherosclerosis 1981 0.75
51 [A case of postprandial hypotension in an elderly subject]. Praxis (Bern 1994) 1996 0.75
52 [Effect of ouabagenin on the hemodynamics of the dog heart in a closed thorax]. Arzneimittelforschung 1969 0.75
53 Apolipoprotein A-IMilano. Correlation between high density lipoprotein subclass distribution and triglyceridemia. Arteriosclerosis 1987 0.75
54 [Hereditary periodic adynamia. Studies on the renin-angiotensin-aldosterone system]. Schweiz Med Wochenschr 1970 0.75
55 Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type II. Eur J Clin Pharmacol 1990 0.75
56 [Analbuminemia. Pathophysiological study of a case]. Schweiz Med Wochenschr 1972 0.75
57 [Premature increase of intraventricular pressure in aortic insufficiency]. Schweiz Med Wochenschr 1968 0.75
58 [Lymph drainage in autoimmune diseases]. Schweiz Rundsch Med Prax 1971 0.75
59 [Mycoplasmosis]. Schweiz Med Wochenschr 1972 0.75
60 [Left ventricular end diastolic volume in humans determined by the themodilution technic]. Arch Kreislaufforsch 1969 0.75
61 [Chronic myopathy in hyperthyroidism. Discussion of the problem with reference to results of radioiodine studies]. Schweiz Med Wochenschr 1967 0.75
62 [Analbuminemia. Physiopathological study of a case]. Schweiz Med Wochenschr 1972 0.75
63 [Monoclonal immunoglobulins with the characteristics of antibodies]. Schweiz Med Wochenschr 1972 0.75
64 [Hypercatabolic hypobetalipoproteinemia caused by autoantibodies]. Verh Dtsch Ges Inn Med 1972 0.75
65 [Hypolipidemias]. Schweiz Med Wochenschr 1975 0.75
66 [Fever of long standing in atrial myxoma]. Schweiz Med Wochenschr 1978 0.75
67 [Infection susceptibility during thoracic duct drainage. Therapy of severe pyocyaneous infections with carbenicillin]. Schweiz Rundsch Med Prax 1971 0.75
68 [Treatment of hyperlipidemia type II with soybeans]. Schweiz Med Wochenschr 1979 0.75
69 [Oral surgical intervention in patients under anticoagulant therapy]. Odontoiatr Prat 1971 0.75
70 [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types]. Schweiz Med Wochenschr 1980 0.75
71 [Clinical observations in isolated vascular pulmonary hypertension]. Wien Z Inn Med 1969 0.75
72 Textured soy protein and serum-cholesterol. Lancet 1980 0.75
73 [Effect of calcium on the contractility increasing action of paired stimulation on the left ventricle of a dog]. Z Kreislaufforsch 1967 0.75
74 [Ventricular volume measurement by thermodilution method]. Verh Dtsch Ges Kreislaufforsch 1968 0.75
75 [Heavy chain disease. A case of IgG-heavy-chain-fragment and IgM-type-K-paraproteinemia with plasma cell leukemia]. Helv Med Acta Suppl 1970 0.75
76 [Proceedings: Hypercholesteremia in idiopathic hirsutism]. Helv Med Acta 1974 0.75
77 [Radiologic case of the month. Spinal localizations revealing Hodgkin's disease]. Arch Pediatr 1999 0.75
78 [Drug treatment of hyperlipidemia]. Ther Umsch 1987 0.75
79 Multicentre study of soybean protein diet for outpatient hyper-cholesterolaemic patients. Lancet 1980 0.75
80 [HL-A antigens in De Quervain's thyroiditis]. Schweiz Med Wochenschr 1976 0.75
81 [Protection of the ischemic myocardium: experiences with verapamil]. Boll Soc Ital Cardiol 1981 0.75
82 [Disorders of the heart rhythm]. Ther Umsch 1972 0.75
83 [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate]. Schweiz Med Wochenschr 1985 0.75
84 [End-diastolic volume and end-diastolic pressure in the left ventricle in men at rest and under stress before and after the beta-receptor blockade]. Schweiz Med Wochenschr 1970 0.75
85 [Neonatal pneumococcus laryngitis]. Arch Fr Pediatr 1989 0.75
86 [Hypocholesteremia in idiopathic hirsutism]. Schweiz Med Wochenschr 1973 0.75
87 [Comparison of left ventricular volume measurement by angiocardiography and thermodilution in the human]. Verh Dtsch Ges Kreislaufforsch 1968 0.75
88 [Acipimox treatment of hyperlipidemia type II]. Schweiz Med Wochenschr 1982 0.75
89 [Familial bradycardia: a family with sick sinus and atrioventricular block]. Schweiz Med Wochenschr 1979 0.75
90 [Influence of calcium on the contractility-increasing effect of paired stimulation on the left ventricle of the dog]. Helv Physiol Pharmacol Acta 1967 0.75
91 [Chronic myopathies in hyperthyroidism. Discussion of the problem with consideration of the results of radioiodide studies]. Schweiz Med Wochenschr 1967 0.75
92 Left ventricular performance at rest, during exercise and electrical pacing in conscious man before and after beta-blockade. Z Kreislaufforsch 1970 0.75
93 Glucagon release following experimental diets in man: effects of soybean and casein enriched diets. Pharmacol Res Commun 1982 0.75
94 [Separation of high density lipoproteins (HDL) using zonal ultracentrifugation in patients with apolipoprotein AI Milano variant]. Schweiz Med Wochenschr 1983 0.75
95 [The effect of ouabagenin. On the hemodynamics of the dog heart]. Cardiologia 1967 0.75
96 [Antibiotic combination therapy and chemotherapeutic prophylaxis]. Schweiz Med Wochenschr 1975 0.75
97 The dispositional enantioselectivity of indobufen in man. Biochem Pharmacol 1992 0.75
98 [Autoantibody-induced serum alpha lipoprotein decrease in carcinoma patients]. Verh Dtsch Ges Inn Med 1972 0.75
99 [Cholesterol crystal embolisms: an exciting search for "pearls"]. Praxis (Bern 1994) 1997 0.75
100 [Modification of serum lipids, lipoproteins and apoproteins AI and B in patients with hyperlipidemia Type IIa and IIb using polyenylphosphatidylcholine]. Schweiz Med Wochenschr 1985 0.75
101 [Criteria in mycoplasmosis]. Dtsch Med Wochenschr 1972 0.75
102 [Diagnosis and therapy of liver abscess]. Schweiz Med Wochenschr 1972 0.75
103 The frequency of hepatitis associated antigen and antibody in patients with paraproteinemia. Vox Sang 1973 0.75
104 [Paraproteins with antibody properties, with special reference to anti-lipoprotein autoantibodies]. Minerva Med 1975 0.75